Hospitalized COVID-19 patients with obesity are significantly more likely to need ICU care
Study did not find higher risk of death in people with obesity, COVID-19
2021-03-20
(Press-News.org) WASHINGTON--People with obesity who are hospitalized with COVID-19 have a significantly higher rate of ICU admissions and longer duration of ICU stay compared to people with a normal body mass index (BMI), according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.
"The association between obesity and a more severe clinical course of COVID-19 highlights the vulnerability of this population during the current pandemic and the need for public health efforts to prevent and treat obesity, in the current pandemic and beyond," said lead researcher Yu Mi Kang, M.D., Ph.D., of Yale New Haven Health in New Haven, Conn.
More than 40% of Americans live with obesity, one of the significant risk factors for COVID-19. Kang and colleagues wanted to determine and describe the impact of obesity on the clinical course of COVID-19, compared with individuals who do not have obesity.
The researchers analyzed data from 3,268 adult patients hospitalized with COVID-19 at five hospitals within the Yale New Haven Health System between March and November 2020.
Among hospitalized patients, 43% had obesity, 15.8% died, and 24.2% required ICU-level care. Patients with obesity were 26% more likely to need ICU care overall than patients who did not have obesity. COVID-19 patients with higher body-mass index (BMI) measurements were even more likely to require ICU care. Individuals with severe obesity, or a BMI of 40 or higher, were twice as likely to need ICU care compared with patients with a normal BMI. The study did not find a higher risk of death in people with obesity compared to those with normal BMI.
"Our work underscores the impact of obesity on the course of COVID-19 and emphasizes the need to ensure that obesity is given appropriate consideration for risk stratification, vaccination protocols and in-hospital COVID-19 management," Kang said.
INFORMATION:
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.
ELSE PRESS RELEASES FROM THIS DATE:
2021-03-20
WASHINGTON--Children with poorly controlled type 1 diabetes have a 10 times higher risk of COVID-19-related complications and death compared to those with well-controlled diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.
"This study shows keeping diabetic children's blood sugar under control is more important than ever during the pandemic," said lead author Manish Raisingani, M.D., of the University of Arkansas for Medical Sciences and Arkansas Children's in Little Rock, Ark. "The findings will help children with type 1 diabetes and their families make better choices about the safety of attending school in person and engaging ...
2021-03-20
WASHINGTON--Commonly used medications for type 2 diabetes and obesity called glucagon like peptide-1 receptor agonists (GLP-1 RAs), are not associated with an increased risk of breast cancer, despite previous studies that suggested a possible link, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.
"GLP-1RAs can be used as adjunct to diet and exercise in subjects with type 2 diabetes and those without type 2 diabetes and excess weight, without an increased risk of breast cancer or noncancerous masses in the breast," said lead researcher Giovana Fagundes Piccoli, M.D., of the Universidade Federal do Rio Grande do Sul in Brazil.
GLP-1 RAs have been shown to be effective in treating obesity and type 2 diabetes ...
2021-03-20
WASHINGTON--New genetic research suggests men can develop characteristics of polycystic ovary syndrome (PCOS)--a common metabolic and reproductive disorder that affects women. The study was presented virtually at ENDO 2021, the Endocrine Society's annual meeting.
PCOS is a common disorder characterized by irregular menstrual periods, disruption of normal metabolism and elevated testosterone levels. PCOS affects up to 10% of all women of reproductive age. The disorder can lead to obesity, diabetes and cardiovascular disease, which are often life-long conditions.
Men who have genetic risk factors ...
2021-03-20
WASHINGTON--Addressing sleep symptoms during menopause may reduce susceptibility to weight gain, according to a small study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.
"Our findings suggest that not only estrogen withdrawal but also sleep disturbances during menopause may contribute to changes in a woman's body that could predispose midlife women to weight gain," said lead researcher Leilah Grant, Ph.D., of Brigham and Women's Hospital in Boston, Mass. "Helping women sleep better during menopause may therefore reduce the chances ...
2021-03-20
WASHINGTON--Endogenous Cushing's syndrome, a rare hormonal disorder, is associated with a threefold increase in death, primarily due to cardiovascular disease and infection, according to a study whose results will be presented at ENDO 2021, the Endocrine Society's annual meeting.
The research, according to the study authors, is the largest systematic review and meta-analysis to date of studies of endogenous (meaning "inside your body") Cushing's syndrome. Whereas Cushing's syndrome most often results from external factors--taking cortisol-like medications such as prednisone--the endogenous type occurs when the body overproduces the hormone cortisol, affecting multiple bodily ...
2021-03-20
WASHINGTON--Two-thirds of patients with chronic endocrine health problems who need close monitoring say they would like to continue with telemedicine follow-up visits after the COVID-19 pandemic ends, according to a survey that will be presented virtually at ENDO 2021, the Endocrine Society's annual meeting. Three-quarters of providers also said they want to continue with telehealth after the pandemic.
"Endocrinology clinics have significant number of patients who need long-term close follow-up for medication adjustments, symptom checks and counseling," said lead researcher Maryam Nemati, M.D., of San Joaquin General Hospital in French Camp, Calif. "Our ...
2021-03-20
WASHINGTON--Treatment of hypothyroidism, which results from an underactive thyroid gland, should be individualized and consideration should be given to alternatives to the first-line therapy, including desiccated thyroid extract and combination therapy to replace the body's two main thyroid hormones, thyroxine (T4) and triiodothyronine (T3). Results of their new randomized clinical study are being presented at ENDO 2021, the Endocrine Society's annual meeting.
Combination therapy has been shown to be equally as effective as the standard treatment with levothyroxine alone, researchers say.
"There are now proven good treatment options for the more than one in 10 patients with hypothyroidism who continue to experience symptoms of fatigue, mental fogginess, weight ...
2021-03-20
WASHINGTON--An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with low testosterone levels, with no evidence of liver toxicity. The findings are being presented virtually at ENDO 2021, the Endocrine Society's annual meeting.
TST is currently available in multiple modes of administration, including implantable pellets, transdermal gels and intramuscular injections.
"For many men with low testosterone levels, an oral option is preferred to avoid issues associated with other ...
2021-03-20
WASHINGTON--Among women who develop diabetes during pregnancy, night owls have a higher risk of complications for mother and baby than early birds do, according to a study whose results will be presented at ENDO 2021, the Endocrine Society's annual meeting.
Compared with other pregnant women with gestational diabetes, those with a preference for evening activity had three times higher the chance of having preeclampsia, which is pregnancy-induced high blood pressure, and four times the rate of their newborns being treated in a neonatal intensive care unit, the study investigators reported.
These findings suggest a ...
2021-03-20
WASHINGTON--Children with achondroplasia, the most common form of disproportionate short stature, grow taller with trends in improved body proportions after two years of daily vosoritide treatment, a new study analysis finds. Results of the industry-sponsored study will be presented at ENDO 2021, the Endocrine Society's annual meeting.
"This is the first robust evidence of a precision therapy for achondroplasia," said the lead investigator, Ravi Savarirayan, M.D., Ph.D., a professor at Murdoch Children's Research Institute at Royal Children's Hospital in Parkville, Australia.
Achondroplasia is a genetic bone growth ...
LAST 30 PRESS RELEASES:
[Press-News.org] Hospitalized COVID-19 patients with obesity are significantly more likely to need ICU care
Study did not find higher risk of death in people with obesity, COVID-19
